Terapia antiretroviral de inibidores da protease contra Toxoplasma gondii

Autores

  • Lianet Monzote Institute of Tropical Medicine ‘Pedro Kouri’; Parasitology Department
  • Marta Rodríguez Institute of Tropical Medicine ‘Pedro Kouri’; Parasitology Department
  • Yenisey Alfonso Institute of Tropical Medicine ‘Pedro Kouri’; Parasitology Department
  • Raymundo Cox Institute of Tropical Medicine ‘Pedro Kouri’; Parasitology Department

Palavras-chave:

Toxoplasma gondii, Antiretroviral protease inhibitors, Toxoplasmic encephalitis

Resumo

The introduction of highly active antiretroviral therapy (HAART) has caused a marked reduction in the occurrence and severity of parasitic infections, including the toxoplasmic encephalitis (TE). These changes have been attributed to the restoration of cell-mediated immunity. This study was developed to examine the activity of six antiretroviral protease inhibitors (API) on Toxoplasma gondii tachyzoites. The six API showed anti-Toxoplasma activity, with IC50 value between 1.4 and 6.6 µg/mL. Further studies at the molecular level should be performed to clarify if the use of API could be beneficial or not for AIDS patients with TE.

Downloads

Os dados de download ainda não estão disponíveis.

Referências

Downloads

Publicado

2013-02-01

Edição

v. 55 n. 1 (2013)

Seção

Relato técnico

Como Citar

Monzote, L., Rodríguez, M., Alfonso, Y., & Cox, R. (2013). Terapia antiretroviral de inibidores da protease contra Toxoplasma gondii . Revista Do Instituto De Medicina Tropical De São Paulo, 55(1), 65-67. https://revistas.usp.br/rimtsp/article/view/53541